Skip to main content

Table 6 Effect on symptoms following administration of pilocarpine solution to patients with Sjӧgren’s syndrome

From: New low-dose liquid pilocarpine formulation for treating dry mouth in Sjögren’s syndrome: clinical efficacy, symptom relief, and improvement in quality of life

  Better Slightly better Unchanged Slightly worse Worse
Post-administration at 60 min* 1 (4.2%) 17 (70.8%) 5 (20.8%) 0 (0%) 1 (4.2%)
Continuous administration** 2 (10.5%) 8 (42.1%) 9 (47.4%) 0 (0%) 0 (0%)
  1. *: n = 24; **: n = 19; values shown are number of individuals (percentage of total)
\